HC Wainwright Analysts Raise Earnings Estimates for CRSP
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Equities research analysts at HC Wainwright increased their Q2 2025 EPS estimates for shares of CRISPR Therapeutics in a report issued on Wednesday, May 7th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings of ($0.93) per share for the quarter, up from […]
